TY - JOUR
T1 - Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors
AU - Chioua, Mourad
AU - Samadi, Abdelouahid
AU - Soriano, Elena
AU - Lozach, Olivier
AU - Meijer, Laurent
AU - Marco-Contelles, José
N1 - Funding Information:
M.C. thanks Instituto de Salud Carlos III (Ministerio de Salud y Consumo) for a post-doctoral fellowship. AS thanks CSIC for a I3P Post-doctoral Contract. J.M.C. thanks also MEC (SAF2006-08764-C02-01), Comunidad de Madrid (S/SAL-0275-2006), and ISCIII [Retic RENEVAS (RD06/0026/1002)] for support. J.M.C. thanks Prof. A. Martínez (IQM, CSIC, Spain) for helpful suggestions and discussions.
PY - 2009/8/15
Y1 - 2009/8/15
N2 - The synthesis and biological evaluation of a number of differently substituted 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives are reported. From the inhibition results on a selection of disease-relevant protein kinases [IC50 (μM) DYRK1A = 11; CDK5 = 0.41; GSK-3 = 1.5] we have observed that 3,6-diamino-4-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (4) constitutes a potential new and simple lead compound in the search of drugs for the treatment of Alzheimer's disease.
AB - The synthesis and biological evaluation of a number of differently substituted 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives are reported. From the inhibition results on a selection of disease-relevant protein kinases [IC50 (μM) DYRK1A = 11; CDK5 = 0.41; GSK-3 = 1.5] we have observed that 3,6-diamino-4-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (4) constitutes a potential new and simple lead compound in the search of drugs for the treatment of Alzheimer's disease.
KW - 3,6-Diamino-1H-pyrazolo[3,4-b]pyridine-5-carbonitriles
KW - Alzheimer's disease
KW - CDK5
KW - GSK-3
KW - Kinase inhibitors
KW - Molecular modelling
KW - Pyrazolo[3,4-b]pyridines
UR - http://www.scopus.com/inward/record.url?scp=67749116230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67749116230&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2009.06.099
DO - 10.1016/j.bmcl.2009.06.099
M3 - Article
C2 - 19615897
AN - SCOPUS:67749116230
SN - 0960-894X
VL - 19
SP - 4566
EP - 4569
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 16
ER -